58 results
8-K
EX-99.1
VBIV
VBI Vaccines Inc.
25 Apr 23
VBI Vaccines Appoints Vaughn Himes to Board of Directors
8:00am
, and quality functions. During his tenure at Seagen, Dr. Himes has helped lead the transition from a research and development-stage company through
8-K
EX-99.1
VBIV
VBI Vaccines Inc.
12 Jul 22
VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer
8:00am
of sales annually. During his tenure at Sanofi Pasteur, Mr. Dillman was also responsible for all segment, consumer, and digital marketing activities
8-K
EX-99.1
k3yymax6jid
7 Dec 20
VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
10:23am
8-K
EX-99.1
ripk74qh
13 Mar 20
VBI Vaccines Appoints Damian Braga to Board of Directors
12:59pm
8-K
EX-99.1
iky a7vx7d
16 Jan 19
VBI Vaccines Appoints Blaine McKee to Board of Directors
12:20pm
10-K
EX-10.34
013 8jivwdqgb
20 Mar 17
Annual report
12:00am
10-K
EX-10.35
7dugs3 p3te
20 Mar 17
Annual report
12:00am
6-K
EX-99.2
sp5ei
10 Feb 15
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
bw0lmi27
10 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
xlda973
13 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
b7rjm8qibdme
1 Jul 14
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
oprk2ey373hajpbucc
27 Jun 14
Current report (foreign)
12:00am